✦ LIBER ✦

Hepatitis C and treatment with pegylated interferon and ribavirin

✍ Scribed by James Gotto; Geoffrey M Dusheiko

Book ID: 116306777
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 143 KB
Volume: 36
Category: Article
ISSN: 1357-2725
DOI: 10.1016/j.biocel.2004.03.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis C with PE

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin

✍ Markus Cornberg; Heiner Wedemeyer; Michael P. Manns 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 513 KB

Retinopathy associated with pegylated in

Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C

✍ Shelly Adams; Mark Ostermeier 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 995 KB

Hepatitis C patients’ self-reported adhe

Hepatitis C patients’ self-reported adherence to treatment with pegylated interferon and ribavirin

✍ J. J. WEISS; L. BHATTI; D. T. DIETERICH; B. R. EDLIN; D. A. FISHBEIN; M. B. GOET 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Pegylated interferon and ribavirin treat

Pegylated interferon and ribavirin treatment in patients with hepatitis C virus associated vasculitis

✍ Kevin Liebovich; Frank Iber; Rodney Tehrani; Aileen Pangan; Elaine Adams; Nikunj 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 24 KB

Treatment of acute hepatitis C with pegy

Treatment of acute hepatitis C with pegylated interferon alpha-2b and ribavirin

✍ Thomas A Capozza; Oscar S Brann; Walter J Coyle; William R Schindler; Timothy A 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 24 KB

Effectiveness of hepatitis C treatment w

Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients

✍ Paul Feuerstadt; Ari L. Bunim; Heriberto Garcia; Jordan J. Karlitz; Hatef Massou 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 2 views

Randomized controlled trials of hepatitis C virus (HCV) therapy with pegylated interferon and ribavirin have demonstrated sustained viral response rates (SVRs) of 54%-63% (efficacy). Treatment results in clinical practice (effectiveness) may not be equivalent. The goal of this study was to assess th